PSEN1 and Alzheimer disease: Due to the many mutation variants of the APP and PS1 genes [29], several double transgenic APP/PS1 mouse model lines have been generated for studying the histopathological and neurobehavioral impact of clinical relevant mutations in the APP and PS1 genes linked to AD [30–32].